Mr Grant Weaver, MA, CDP, MAC, LMHC in Agana Heights, GU - Counselor

Mr Grant Weaver, MA, CDP, MAC, LMHC is a Counselor - Addiction (substance Use Disorder) based in Agana Heights, Guam. Mr Grant Weaver is licensed to practice in Washington (license number CP00002621) and his current practice location is 178 Francisco Xavier Drive, Apartment 9 Cliff Condos & Guest House, Agana Heights, Guam. He can be reached at his office (for appointments etc.) via phone at (671) 482-6095.

NPI number for Mr Grant Weaver is 1356482921 and his current mailing address is Psc 490, Box 9096, Fpo, Armed Forces Pacific. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1356482921.

Contact Information

	Mr Grant Weaver, MA, CDP, MAC, LMHC
	178 Francisco Xavier Drive, Apartment 9 Cliff Condos & Guest House, Agana Heights, GU 96910
	(671) 482-6095
	(671) 344-9522

Healthcare Provider's Profile

Full Name	Mr Grant Weaver
Gender	Male
Speciality	Counselor - Addiction (substance Use Disorder)
Location	178 Francisco Xavier Drive, Agana Heights, Guam
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1356482921
Provider Enumeration Date: 02/08/2007
Last Update Date: 04/13/2011

Medical Identifiers

Medical identifiers for Mr Grant Weaver such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356482921	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	CP00002621 (Washington)	Primary
101YM0800X	Counselor - Mental Health	LH00003794 (Washington)	Secondary
101YP1600X	Counselor - Pastoral	(Guam)	Secondary
101YP2500X	Counselor - Professional	4294 (Washington)	Secondary
106H00000X	Marriage & Family Therapist	IMF-97 (Guam)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Grant Weaver is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Grant Weaver, MA, CDP, MAC, LMHC Psc 490, Box 9096, Fpo, AP 96538-0490 Ph: (671) 344-9266	Mr Grant Weaver, MA, CDP, MAC, LMHC 178 Francisco Xavier Drive, Apartment 9 Cliff Condos & Guest House, Agana Heights, GU 96910 Ph: (671) 482-6095

News Archive

Teen drivers with ADHD more likely to crash and get traffic violations for risky driving

Teen drivers diagnosed with attention-deficit hyperactivity disorder are significantly more likely to crash, be issued traffic and moving violations, and engage in risky driving behaviors than their peers without ADHD, according to a Children's Hospital of Philadelphia study published today in the journal Pediatrics.

Obese people take less time to feel full than those of normal weight

Obese people take less time to feel full than those of normal weight. Despite this, they consume more calories. A faster speed of eating could play an important role in obesity, according to a study funded by the Swiss National Science Foundation.

Results from Intarcia's two phase 3 clinical trials of ITCA 650 to be presented at ADA's Scientific Session

Intarcia Therapeutics, Inc. today announced the presentation of results from its first two phase 3 clinical trials (FREEDOM-1 and FREEDOM-1 HBL) of its late-stage investigational candidate ITCA 650 (exenatide delivered continuously via a small matchstick-size subcutaneous osmotic mini-pump just once or twice yearly) at the 75th Scientific Sessions of the American Diabetes Association.

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

Japanese woman diagnosed with frosted branch angiitis

Leukemias and lymphomas are life-threatening malignancies affecting white blood cells and the immune system; fortunately, radiotherapy and chemotherapy, combined with stem cell therapy, can improve survival significantly.

Counselor in Agana Heights, GU

Risha Aguon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 178 Francisco Javier Ave Unit C-12, Agana Heights, GU 96910 Phone: 671-477-3311
Valerie Jean Cruz Mansapit, Counselor Medicare: Not Enrolled in Medicare Practice Location: 498 Chalan Palosyo, Agana Heights, GU 96910 Phone: 671-475-5760

Mr Grant Weaver, MA, CDP, MAC, LMHC - Counselor in Agana Heights, GU